NCT00253032
Terminated
Phase 3
PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.
Fralex Therapeutics0 sitesNovember 15, 2005
ConditionsChronic Musculoskeletal Pain
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Chronic Musculoskeletal Pain
- Sponsor
- Fralex Therapeutics
- Status
- Terminated
- Last Updated
- 20 years ago
Overview
Brief Summary
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 3
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia PopulationFibromyalgiaPainNCT00450905Fralex Therapeutics200
Completed
Phase 3
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back PainPainNCT01019824Newron Pharmaceuticals SPA411
Not yet recruiting
Not Applicable
NEUROMOdulation Pain Therapy in Combination With Intensive PhysiotherapySpinal CordNCT05544175Charles University, Czech Republic10
Unknown
Not Applicable
The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract SymptomsBladder HypersensitivityNCT04807569Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation68
Completed
Phase 2
Neurotropin Treatment of FibromyalgiaFibromyalgiaNCT00366535National Institute of Nursing Research (NINR)56